Global Proton Pump Inhibitors for Gastric Acid Therapy Market Growth 2022-2028
Proton pump inhibitors (PPIs) reduce the production of acid by blocking the enzyme in the wall of the stomach that produces acid. Acid is necessary for the formation of most ulcers in the esophagus, stomach, and duodenum, and the reduction of acid with PPIs prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal.
The global market for Proton Pump Inhibitors for Gastric Acid Therapy is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Proton Pump Inhibitors for Gastric Acid Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Proton Pump Inhibitors for Gastric Acid Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Proton Pump Inhibitors for Gastric Acid Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Proton Pump Inhibitors for Gastric Acid Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Proton Pump Inhibitors for Gastric Acid Therapy players cover Takeda, Pfizer, AstraZeneca, Bayer and Sun Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Proton Pump Inhibitors for Gastric Acid Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Proton Pump Inhibitors for Gastric Acid Therapy market, with both quantitative and qualitative data, to help readers understand how the Proton Pump Inhibitors for Gastric Acid Therapy market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Units.
Market Segmentation:
The study segments the Proton Pump Inhibitors for Gastric Acid Therapy market and forecasts the market size by Type (Dexlansoprazole, Esomeprazole and Lansoprazole), by Application (Hospital Pharmacy, Retail Pharmacy and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Dexlansoprazole
Esomeprazole
Lansoprazole
Omeprazole
Pantoprazole
Rabeprazole
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Takeda
Pfizer
AstraZeneca
Bayer
Sun Pharma
Teva
Eisai Co.
Mylan
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Eastchina Pharma
Chapter Introduction
Chapter 1: Scope of Proton Pump Inhibitors for Gastric Acid Therapy, Research Methodology, etc.
Chapter 2: Executive Summary, global Proton Pump Inhibitors for Gastric Acid Therapy market size (sales and revenue) and CAGR, Proton Pump Inhibitors for Gastric Acid Therapy market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Proton Pump Inhibitors for Gastric Acid Therapy sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Proton Pump Inhibitors for Gastric Acid Therapy sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Proton Pump Inhibitors for Gastric Acid Therapy market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Takeda, Pfizer, AstraZeneca, Bayer, Sun Pharma, Teva, Eisai Co., Mylan and AOSAIKANG Pharma, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Proton Pump Inhibitors for Gastric Acid Therapy by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Proton Pump Inhibitors for Gastric Acid Therapy by Country/Region, 2017, 2022 & 2028
2.2 Proton Pump Inhibitors for Gastric Acid Therapy Segment by Type
2.2.1 Dexlansoprazole
2.2.2 Esomeprazole
2.2.3 Lansoprazole
2.2.4 Omeprazole
2.2.5 Pantoprazole
2.2.6 Rabeprazole
2.3 Proton Pump Inhibitors for Gastric Acid Therapy Sales by Type
2.3.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Type (2017-2022)
2.3.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue and Market Share by Type (2017-2022)
2.3.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sale Price by Type (2017-2022)
2.4 Proton Pump Inhibitors for Gastric Acid Therapy Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Proton Pump Inhibitors for Gastric Acid Therapy Sales by Application
2.5.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Sale Market Share by Application (2017-2022)
2.5.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue and Market Share by Application (2017-2022)
2.5.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sale Price by Application (2017-2022)
3 Global Proton Pump Inhibitors for Gastric Acid Therapy by Company
3.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Breakdown Data by Company
3.1.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Annual Sales by Company (2020-2022)
3.1.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Company (2020-2022)
3.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Annual Revenue by Company (2020-2022)
3.2.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Company (2020-2022)
3.2.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Company (2020-2022)
3.3 Global Proton Pump Inhibitors for Gastric Acid Therapy Sale Price by Company
3.4 Key Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Product Location Distribution
3.4.2 Players Proton Pump Inhibitors for Gastric Acid Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Proton Pump Inhibitors for Gastric Acid Therapy by Geographic Region
4.1 World Historic Proton Pump Inhibitors for Gastric Acid Therapy Market Size by Geographic Region (2017-2022)
4.1.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Annual Revenue by Geographic Region
4.2 World Historic Proton Pump Inhibitors for Gastric Acid Therapy Market Size by Country/Region (2017-2022)
4.2.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Annual Sales by Country/Region (2017-2022)
4.2.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Annual Revenue by Country/Region
4.3 Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales Growth
4.4 APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales Growth
4.5 Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Growth
4.6 Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales Growth
5 Americas
5.1 Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales by Country
5.1.1 Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales by Country (2017-2022)
5.1.2 Americas Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Country (2017-2022)
5.2 Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales by Type
5.3 Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales by Region
6.1.1 APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales by Region (2017-2022)
6.1.2 APAC Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Region (2017-2022)
6.2 APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales by Type
6.3 APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Proton Pump Inhibitors for Gastric Acid Therapy by Country
7.1.1 Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales by Country (2017-2022)
7.1.2 Europe Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Country (2017-2022)
7.2 Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales by Type
7.3 Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy by Country
8.1.1 Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales by Country (2017-2022)
8.1.2 Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Country (2017-2022)
8.2 Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales by Type
8.3 Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Proton Pump Inhibitors for Gastric Acid Therapy
10.3 Manufacturing Process Analysis of Proton Pump Inhibitors for Gastric Acid Therapy
10.4 Industry Chain Structure of Proton Pump Inhibitors for Gastric Acid Therapy
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Proton Pump Inhibitors for Gastric Acid Therapy Distributors
11.3 Proton Pump Inhibitors for Gastric Acid Therapy Customer
12 World Forecast Review for Proton Pump Inhibitors for Gastric Acid Therapy by Geographic Region
12.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Market Size Forecast by Region
12.1.1 Global Proton Pump Inhibitors for Gastric Acid Therapy Forecast by Region (2023-2028)
12.1.2 Global Proton Pump Inhibitors for Gastric Acid Therapy Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Proton Pump Inhibitors for Gastric Acid Therapy Forecast by Type
12.7 Global Proton Pump Inhibitors for Gastric Acid Therapy Forecast by Application
13 Key Players Analysis
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.1.3 Takeda Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.2.3 Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.3.3 AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.4.3 Bayer Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Sun Pharma
13.5.1 Sun Pharma Company Information
13.5.2 Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.5.3 Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sun Pharma Main Business Overview
13.5.5 Sun Pharma Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.6.3 Teva Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
13.7 Eisai Co.
13.7.1 Eisai Co. Company Information
13.7.2 Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.7.3 Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Eisai Co. Main Business Overview
13.7.5 Eisai Co. Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.8.3 Mylan Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 AOSAIKANG Pharma
13.9.1 AOSAIKANG Pharma Company Information
13.9.2 AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.9.3 AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 AOSAIKANG Pharma Main Business Overview
13.9.5 AOSAIKANG Pharma Latest Developments
13.10 Luoxin Pharma
13.10.1 Luoxin Pharma Company Information
13.10.2 Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.10.3 Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Luoxin Pharma Main Business Overview
13.10.5 Luoxin Pharma Latest Developments
13.11 LIVZON
13.11.1 LIVZON Company Information
13.11.2 LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.11.3 LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 LIVZON Main Business Overview
13.11.5 LIVZON Latest Developments
13.12 Eastchina Pharma
13.12.1 Eastchina Pharma Company Information
13.12.2 Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
13.12.3 Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Eastchina Pharma Main Business Overview
13.12.5 Eastchina Pharma Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Proton Pump Inhibitors for Gastric Acid Therapy Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Proton Pump Inhibitors for Gastric Acid Therapy Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Dexlansoprazole
Table 4. Major Players of Esomeprazole
Table 5. Major Players of Lansoprazole
Table 6. Major Players of Omeprazole
Table 7. Major Players of Pantoprazole
Table 8. Major Players of Rabeprazole
Table 9. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales by Type (2017-2022) & (Units)
Table 10. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Type (2017-2022)
Table 11. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Type (2017-2022) & ($ million)
Table 12. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Type (2017-2022)
Table 13. Global Proton Pump Inhibitors for Gastric Acid Therapy Sale Price by Type (2017-2022) & (US$/Unit)
Table 14. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales by Application (2017-2022) & (Units)
Table 15. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Application (2017-2022)
Table 16. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Application (2017-2022)
Table 17. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Application (2017-2022)
Table 18. Global Proton Pump Inhibitors for Gastric Acid Therapy Sale Price by Application (2017-2022) & (US$/Unit)
Table 19. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales by Company (2020-2022) & (Units)
Table 20. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Company (2020-2022)
Table 21. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Company (2020-2022)
Table 23. Global Proton Pump Inhibitors for Gastric Acid Therapy Sale Price by Company (2020-2022) & (US$/Unit)
Table 24. Key Manufacturers Proton Pump Inhibitors for Gastric Acid Therapy Producing Area Distribution and Sales Area
Table 25. Players Proton Pump Inhibitors for Gastric Acid Therapy Products Offered
Table 26. Proton Pump Inhibitors for Gastric Acid Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales by Geographic Region (2017-2022) & (Units)
Table 30. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share Geographic Region (2017-2022)
Table 31. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales by Country/Region (2017-2022) & (Units)
Table 34. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Country/Region (2017-2022)
Table 35. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales by Country (2017-2022) & (Units)
Table 38. Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Country (2017-2022)
Table 39. Americas Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Country (2017-2022)
Table 41. Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales by Type (2017-2022) & (Units)
Table 42. Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Type (2017-2022)
Table 43. Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales by Application (2017-2022) & (Units)
Table 44. Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Application (2017-2022)
Table 45. APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales by Region (2017-2022) & (Units)
Table 46. APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Region (2017-2022)
Table 47. APAC Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Region (2017-2022)
Table 49. APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales by Type (2017-2022) & (Units)
Table 50. APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Type (2017-2022)
Table 51. APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales by Application (2017-2022) & (Units)
Table 52. APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Application (2017-2022)
Table 53. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales by Country (2017-2022) & (Units)
Table 54. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Country (2017-2022)
Table 55. Europe Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Country (2017-2022)
Table 57. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales by Type (2017-2022) & (Units)
Table 58. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Type (2017-2022)
Table 59. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales by Application (2017-2022) & (Units)
Table 60. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales by Country (2017-2022) & (Units)
Table 62. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales by Type (2017-2022) & (Units)
Table 66. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales by Application (2017-2022) & (Units)
Table 68. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Proton Pump Inhibitors for Gastric Acid Therapy
Table 70. Key Market Challenges & Risks of Proton Pump Inhibitors for Gastric Acid Therapy
Table 71. Key Industry Trends of Proton Pump Inhibitors for Gastric Acid Therapy
Table 72. Proton Pump Inhibitors for Gastric Acid Therapy Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Proton Pump Inhibitors for Gastric Acid Therapy Distributors List
Table 75. Proton Pump Inhibitors for Gastric Acid Therapy Customer List
Table 76. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Forecast by Region (2023-2028) & (Units)
Table 77. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Forecast by Region
Table 78. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales Forecast by Country (2023-2028) & (Units)
Table 81. Americas Proton Pump Inhibitors for Gastric Acid Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales Forecast by Region (2023-2028) & (Units)
Table 83. APAC Proton Pump Inhibitors for Gastric Acid Therapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Forecast by Country (2023-2028) & (Units)
Table 85. Europe Proton Pump Inhibitors for Gastric Acid Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales Forecast by Country (2023-2028) & (Units)
Table 87. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Forecast by Type (2023-2028) & (Units)
Table 89. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Forecast by Application (2023-2028) & (Units)
Table 93. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share Forecast by Application (2023-2028)
Table 96. Takeda Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 97. Takeda Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 98. Takeda Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 99. Takeda Main Business
Table 100. Takeda Latest Developments
Table 101. Pfizer Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 102. Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 103. Pfizer Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 104. Pfizer Main Business
Table 105. Pfizer Latest Developments
Table 106. AstraZeneca Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 107. AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 108. AstraZeneca Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 109. AstraZeneca Main Business
Table 110. AstraZeneca Latest Developments
Table 111. Bayer Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 112. Bayer Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 113. Bayer Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 114. Bayer Main Business
Table 115. Bayer Latest Developments
Table 116. Sun Pharma Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 117. Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 118. Sun Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 119. Sun Pharma Main Business
Table 120. Sun Pharma Latest Developments
Table 121. Teva Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 122. Teva Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 123. Teva Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 124. Teva Main Business
Table 125. Teva Latest Developments
Table 126. Eisai Co. Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 127. Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 128. Eisai Co. Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 129. Eisai Co. Main Business
Table 130. Eisai Co. Latest Developments
Table 131. Mylan Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 132. Mylan Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 133. Mylan Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 134. Mylan Main Business
Table 135. Mylan Latest Developments
Table 136. AOSAIKANG Pharma Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 137. AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 138. AOSAIKANG Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 139. AOSAIKANG Pharma Main Business
Table 140. AOSAIKANG Pharma Latest Developments
Table 141. Luoxin Pharma Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 142. Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 143. Luoxin Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 144. Luoxin Pharma Main Business
Table 145. Luoxin Pharma Latest Developments
Table 146. LIVZON Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 147. LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 148. LIVZON Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 149. LIVZON Main Business
Table 150. LIVZON Latest Developments
Table 151. Eastchina Pharma Basic Information, Proton Pump Inhibitors for Gastric Acid Therapy Manufacturing Base, Sales Area and Its Competitors
Table 152. Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Product Offered
Table 153. Eastchina Pharma Proton Pump Inhibitors for Gastric Acid Therapy Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 154. Eastchina Pharma Main Business
Table 155. Eastchina Pharma Latest Developments
List of Figures
Figure 1. Picture of Proton Pump Inhibitors for Gastric Acid Therapy
Figure 2. Proton Pump Inhibitors for Gastric Acid Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Proton Pump Inhibitors for Gastric Acid Therapy Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Dexlansoprazole
Figure 10. Product Picture of Esomeprazole
Figure 11. Product Picture of Lansoprazole
Figure 12. Product Picture of Omeprazole
Figure 13. Product Picture of Pantoprazole
Figure 14. Product Picture of Rabeprazole
Figure 15. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Type in 2021
Figure 16. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Type (2017-2022)
Figure 17. Proton Pump Inhibitors for Gastric Acid Therapy Consumed in Hospital Pharmacy
Figure 18. Global Proton Pump Inhibitors for Gastric Acid Therapy Market: Hospital Pharmacy (2017-2022) & (Units)
Figure 19. Proton Pump Inhibitors for Gastric Acid Therapy Consumed in Retail Pharmacy
Figure 20. Global Proton Pump Inhibitors for Gastric Acid Therapy Market: Retail Pharmacy (2017-2022) & (Units)
Figure 21. Proton Pump Inhibitors for Gastric Acid Therapy Consumed in Other
Figure 22. Global Proton Pump Inhibitors for Gastric Acid Therapy Market: Other (2017-2022) & (Units)
Figure 23. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Application (2017-2022)
Figure 24. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Application in 2021
Figure 25. Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Company in 2021
Figure 27. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Geographic Region in 2021
Figure 29. Global Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Region (2017-2022)
Figure 30. Global Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Country/Region in 2021
Figure 31. Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales 2017-2022 (Units)
Figure 32. Americas Proton Pump Inhibitors for Gastric Acid Therapy Revenue 2017-2022 ($ Millions)
Figure 33. APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales 2017-2022 (Units)
Figure 34. APAC Proton Pump Inhibitors for Gastric Acid Therapy Revenue 2017-2022 ($ Millions)
Figure 35. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales 2017-2022 (Units)
Figure 36. Europe Proton Pump Inhibitors for Gastric Acid Therapy Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales 2017-2022 (Units)
Figure 38. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Revenue 2017-2022 ($ Millions)
Figure 39. Americas Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Country in 2021
Figure 40. Americas Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Country in 2021
Figure 41. United States Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Region in 2021
Figure 46. APAC Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Regions in 2021
Figure 47. China Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Country in 2021
Figure 54. Europe Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Country in 2021
Figure 55. Germany Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Proton Pump Inhibitors for Gastric Acid Therapy Revenue Market Share by Country in 2021
Figure 62. Egypt Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Proton Pump Inhibitors for Gastric Acid Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Proton Pump Inhibitors for Gastric Acid Therapy in 2021
Figure 68. Manufacturing Process Analysis of Proton Pump Inhibitors for Gastric Acid Therapy
Figure 69. Industry Chain Structure of Proton Pump Inhibitors for Gastric Acid Therapy
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets